MariMedMRMD -3.57% Days Payable is 55.97 as of Mar. 2026, which is 3% above its 10-year median of 54.15. The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, MariMed ranks worse than 78.15% on this metric.
MariMed's average Accounts Payable for the
three
months ended in Mar. 2026 was $14.8 Mil. MariMed's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $24.2 Mil.
Hence, MariMed's Days Payable for the
three
months ended in Mar. 2026 was 55.97.
The historical rank and industry rank for MariMed's Days Payable or its related term are showing as below:
MRMD'
s Days Payable Range Over the Past 10 Years
Min: 30.55 Med: 54.15 Max: 304.71
Current: 46.71
During the past 13 years, MariMed's highest Days Payable was 304.71. The lowest was 30.55. And the median was 54.15.
MRMD's Days Payable is ranked worse than 78.15% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs MRMD: 46.71
MariMed's Days Payable
increased
from Mar. 2025 (54.31) to Mar. 2026 (55.97).
It may suggest that MariMeddelayed paying its suppliers.
MariMed Days Payable Related Terms
MariMed Days Payable Historical Data
* Premium members only.
The historical data trend for MariMed's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, MariMed's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MariMed Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MariMed's Days Payable distribution charts can be found below:
* The bar in red indicates where MariMed's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
MariMed's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MariMed (MRMD) has a Days Payable of 55.97 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MariMed and its competitors. This is near median its historical median of 54.15. Over the past decade, MariMed's Days Payable has ranged from 30.55 to 304.71. According to the industry distribution chart, MariMed ranks #719 out of 920 companies in the Drug Manufacturers industry, placing it in the top 78.2%.
Is MariMed's Days Payable too high?
MariMed's current Days Payable of 55.97 is near median its 10-year median of 54.15. Over the past 10 years, this metric has ranged from a low of 30.55 to a high of 304.71. The Drug Manufacturers industry median Days Payable is 90.84. MariMed's value of 55.97 is 38.4% below this industry median. Based on the distribution chart, MariMed ranks #719 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does MariMed's Days Payable compare to CPHI and RMTI?
According to the Drug Manufacturers industry distribution chart, MariMed ranks #719 out of 920 companies for Days Payable. This places MariMed in the lower half of its industry. The industry median Days Payable is 90.84. MariMed's value of 55.97 is 38.4% below this benchmark. Historically, MariMed's own Days Payable has ranged from 30.55 to 304.71 over the past decade. While the company's 10-year median is 54.15 vs. the industry median of 90.84, MariMed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MariMed's current Days Payable of 55.97 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MariMed and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MariMed's current Days Payable is 55.97, which is near median its own 10-year median of 54.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MariMed stock overvalued right now?
Based on GuruFocus' analysis, MariMed (MRMD) is currently considered Possible Value Trap. The stock's GF Value™ is $0.16, compared to a current price of $0.07 — trading 56.1% below its estimated fair value. The current Days Payable is 55.97, which is near median its 10-year median of 54.15 and 38.4% below the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MariMed (MRMD), the current Days Payable is 55.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MariMed Inc is a multi-state cannabis operator in the United States dedicated to improving lives every day through its high-quality products. The company develops, owns, and manages seed to sale state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It has created and continues to develop its own brands of cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other top cannabis products, in select domestic markets. Its operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which it operates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRMD has been successfully added to your 